글리시리진

0(0명)
문서 역사

Glycyrrhizin (or glycyrrhizic acid or glycyrrhizinic acid) is the chief sweet-tasting constituent of Glycyrrhiza glabra (liquorice) root. Structurally, it is a saponin used as an emulsifier and gel-forming agent in foodstuffs and cosmetics. Its aglycone is enoxolone assessed as a prodrug used in Japan to reduce the risk of liver cancer in people with chronic hepatitis C.

글리시리진 (또는 글리시리진 산)은 글리시리자 글라브라 (감초) 뿌리의 달콤한 맛을내는 주요 성분이다. 구조적으로, 그것은 식품 및 화장품에서 유화제 및 겔 형성 제로서 사용되는 사포닌이다. C 형 간염 환자에서 간암의 위험을 줄이기 위해 일본에서 사용되는 "약물 (prodrug)"로 평가되는 이의 아실 콘 (aglycone)은 에노 옥 솔론이다.

Glycyrrhizin adverse effects

 

Research

Glycyrrhizin is under laboratory and preliminary clinical research for its possible activity against common viruses, such as hepatitis C.4 In vitro, glycyrrhizin inhibits the enzyme 11β-hydroxysteroid dehydrogenase.8

Pharmacokinetics

After oral ingestion, glycyrrhizin is first hydrolysed to 18β-glycyrrhetinic acid (enoxolone) by intestinal bacteria. After complete absorption from the gut, 18β-glycyrrhetinic acid is metabolised to 3β-monoglucuronyl-18β-glycyrrhetinic acid in the liver. This metabolite then circulates in the bloodstream. Consequently, its oral bioavailability is poor.quantify] The main part is eliminated by bile and only a minor part (0.31–0.67%) by urine.9 After oral ingestion of 600 mg of glycyrrhizin the metabolite appeared in urine after 1.5 to 14 hours. Maximal concentrations (0.49 to 2.69 mg/l) were achieved after 1.5 to 39 hours and metabolite can be detected in the urine after 2 to 4 days.

Flavouring properties

Glycyrrhizin is obtained as an extract from licorice root after maceration and boiling in water.10 Licorice extract (glycyrrhizin) is sold in the United States as a liquid, paste, or spray-dried powder.When in specified amounts, it is approved for use as a flavor and aroma in manufactured foods, beverages, candies, dietary supplements, and seasonings.10 It is 30 to 50 times as sweet as sucrose (table sugar).811

See also

References

  1. ^ van Rossum, TG; Vulto, AG; Hop, WC; Schalm, SW (December 1999). "Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection"Clinical Therapeutics21 (12): 2080–90. doi:10.1016/S0149-2918(00)87239-2hdl:1765/73160PMID 10645755.
  2. ^ Ploeger, B; Mensinga, T; Sips, A; Seinen, W; Meulenbelt, J; DeJongh, J (May 2001). "The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling". Drug Metabolism Reviews33 (2): 125–47. doi:10.1081/DMR-100104400PMID 11495500.
  3. ^ Arase, Yasuji; Ikeda, Kenji; Murashima, Naoya; Chayama, Kazuaki; Tsubota, Akihito; Koida, Isao; Suzuki, Yoshiyuki; Saitoh, Satoshi; Kobayashi, Masahiro; Kumada, Hiromitsu (15 April 1997). "The long term efficacy of glycyrrhizin in chronic hepatitis C patients". Cancer79 (8): 1494–1500. doi:<1494::AID-CNCR8>3.0.CO;2-B 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B.
  4. 이동:a b Fiore, C; Eisenhut, M; Krausse, R; Ragazzi, E; Pellati, D; Armanini, D; Bielenberg, J (2008). "Antiviral effects of Glycyrrhiza species". Phytotherapy Research22 (2): 141–8. doi:10.1002/ptr.2295PMID 17886224.
  5. 이동:a b c "Black Licorice: Trick or Treat?". US Food and Drug Administration. 30 October 2017. Retrieved 15 December 2017.
  6. 이동:a b c Penninkilampi, R; Eslick, E. M; Eslick, G. D (2017). "The association between consistent licorice ingestion, hypertension and hypokalaemia: A systematic review and meta-analysis". Journal of Human Hypertension31 (11): 699–707. doi:10.1038/jhh.2017.45PMID 28660884.
  7. ^ Ferrari, P.; Sansonnens, A.; Dick, B.; Frey, F. J. (2001). "In Vivo 11 -HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice". Hypertension38 (6): 1330–6. CiteSeerX 10.1.1.620.857doi:10.1161/hy1101.096112PMID 11751713.
  8. 이동:a b c Asl, MN; Hosseinzadeh, H (1 June 2008). "Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds". Phytotherapy Research22 (6): 709–24. doi:10.1002/ptr.2362PMID 18446848.
  9. 이동:a b Kočevar Glavač, Nina; Kreft, Samo (2012). "Excretion profile of glycyrrhizin metabolite in human urine". Food Chemistry131: 305–308. doi:10.1016/j.foodchem.2011.08.081.
  10. 이동:a b c "Sec. 184.1408 Licorice and licorice derivatives". US Food and Drug Administration, Code of Federal Regulations Title 21, 21CFR184.1408. 1 April 2017. Retrieved 15 December 2017.
  11. ^ "Glycyrrhizic Acid"PubChem. National Institutes of Health. Retrieved 24 February 2014.

External links

댓글 0